Patients with MS receiving ocrelizumab are at higher risk for serious infection compared with those treated with platform injectable therapies.

Compared with placebo, single-dose clesrovimab 105 mg was protective against mild, moderate, and severe respiratory syncytial virus infection in healthy infants. A single intramuscular dose of ...

Among screening-adherent members, direct mail was the most effective and cost-saving strategy; for overdue members, direct mail was also more effective than usual care and generated an additional ...

The FSIS said the Livingston, California–based company received multiple complaints from consumers who discovered wood in the products; at least 5 people have been injured. HealthDay News — Foster ...

There’s an urgent shortage of medicines for malaria, HIV, tuberculosis and other life-threatening illnesses. HealthDay News — More than 200 health centers in eastern Congo are running out of essential ...